Prostate cancer and chronic prostatitis

被引：25

作者：

Sandhu J.S. ^{[1
]}

机构：

[1] Memorial Sloan-Kettering Cancer Center, New York, NY 10021

来源：

Current Urology Reports | 2008年 / 9卷 / 4期

关键词：

Prostate Cancer; Prostatitis; Chronic Prostatitis; Chronic Pelvic Pain Syndrome; Radical Prostatectomy Specimen;

D O I：

10.1007/s11934-008-0056-6

中图分类号：

学科分类号：

摘要：

Prostate cancer and chronic prostatitis are prevalent disorders in men. The cause of prostate cancer and chronic prostatitis is multifocal and diverse. Both disorders exhibit characteristic elevation of serum prostate-specific antigen, currently the primary screening test for prostate cancer. Prostate inflammation, regardless of cause, is the histopathologic hallmark of chronic prostatitis. In general, inflammation is associated with multiple cancers, and prostate inflammation, in particular, is a suggested factor in the development and progression of prostate cancer. This review addresses the Jink between chronic prostatitis and prostate cancer, especially as it relates to clinical practice. Copyright © 2008 by Current Medicine Group LLC.

引用

页码：328 / 332

页数：4

共 27 条

[1]

Cancer facts and figures, (2006)

[2]

Penson D.F., Chan J.M., Prostate Cancer, Urologic Diseases in America, pp. 71-122, (2007)

[3]

DeMarzo A.M., Platz E.A., Sutcliffe S., Et al., Inflammation in prostate carcinogenesis, Nat Rev Cancer, 7, pp. 256-269, (2007)

[4]

Roberts R.O., Lieber M.M., Bostwick D.G., Jacobsen S.J., A review of clinical and pathological prostatitis syndromes, Urology, 49, pp. 809-821, (1997)

[5]

Roberts R.O., Lieber M.M., Rhodes T., Et al., Prevalence of a physician-assigned diagnosis of prostatitis: The Olmsted County Study of Urinary Symptoms and Health Status Among Men, Urology, 51, pp. 578-584, (1998)

[6]

Dennis L.K., Lynch C.F., Torner J.C., Epidemiologic association between prostatitis and prostate cancer, Urology, 60, pp. 78-83, (2002)

[7]

Sarma A.V., McLaughlin J.C., Wallner, Et al., Sexual behavior, sexually transmitted diseases, and prostatitis: The risk of prostate cancer in black men, J Urol, 176, pp. 1108-1113, (2006)

[8]

Coussens L.M., Werb Z., Inflammation and cancer, Nature, 420, pp. 860-867, (2002)

[9]

Basler J.W., Piazza G.A., Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective inhibitors for prostate cancer chemoprevention, J Urol, 171, (2004)

[10]

Shah R., Mucci N.R., Amin A., Et al., Postatrophic hyperplasia of the prostate gland. Neoplastic precursor or innocent bystander?, Am J Pathol, 158, pp. 1767-1773, (2001)

← 1 2 3 →